Mechanisms of Gastrointestinal Toxicity of Nonsteroidal Anti-Inflammatory Drugs
- 1 January 1989
- journal article
- research article
- Published by Informa UK Limited in Scandinavian Journal of Gastroenterology
- Vol. 24 (sup163), 9-16
- https://doi.org/10.3109/00365528909091169
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) induce GI damage by multiple, in some cases interrelated, mechanisms. They vary in ulcerogenic activity in different regions of the GI tract. These differences in ulcerogenicity of NSAIDs are due to (a) differing kinetics of absorption in various regions of the GI tract, intracellular distribution within the mucosal cells, and systemic availability, and (b) quantitative and qualitative differences in the biochemical or physiologic systems affected by the drugs. In the stomach, where acid/pepsin influence the ulcerogenic effects of most NSAIDs, prostaglandin (PG)-dependent and PG-independent factors are responsible for the ulcerogenicity of NSAIDs. PG-dependent factors can include the influences of PGs on mucus-bicarbonate secretion, regulation of acid secretion, and blood flow. Recent evidence suggests that CO inhibition may, by diversion of arachidonate, cause enhanced production of vasoconstrictor peptidoleukotrienes and oxyradicals produced by the lipoxygenase pathway, and this may contribute to the genesis of vascular and other mucosal changes induced by NSAIDs. Non-PG-dependent effects of NSAIDs include (a) physical effects of the acidic molecules on surface mucosal cell membranes and mucus, (b) oxyradical production, (c) cytotoxic effects on parietal cells, and (d) inhibitory effects on mucus synthesis, mitochondrial ATP production, cyclic nucleotide production, and a range of other cellular metabolic effects influencing mucosal metabolism and cellular regeneration. In the intestinal tract, two major factors influence the ulcerogenicity of NSAIDs: their capacity to undergo enterophepatic recirculation and the presence of bacteria, which may in part contribute to a immunoinflammatory changes.Keywords
This publication has 34 references indexed in Scilit:
- Interplay between anti-inflammatory drugs and eicosanoids in gastrointestinal damagePublished by Springer Science and Business Media LLC ,1988
- The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in miceInflammation Research, 1987
- Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatmentJournal of Pharmacy and Pharmacology, 1987
- Effect of Indomethacin on Gastric Mucosal Prostaglandins in HumansGastroenterology, 1987
- Mechanisms of gastric contrasted with intestinal damage by non-steroidal anti-inflammatory drugsPublished by Springer Science and Business Media LLC ,1987
- Gastroduodenal Mucosal Defence Mechanisms and the Action of Non-steroidal Anti-inflammatory AgentsScandinavian Journal of Gastroenterology, 1987
- Relationship between Drug Absorption, Inhibition of Cyclooxygenase and Lipoxygenase Pathways, and Development of Gastric Mucosal Damage by Nonsteroidal Antiinflammatory Drugs in Rats and PigsPublished by Springer Science and Business Media LLC ,1985
- A Biochemical Basis for the Gastrointestinal Toxicity of Non-steroid Antirheumatoid DrugsPublished by Springer Science and Business Media LLC ,1984
- Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibitionProstaglandins, 1980
- EFFECTS OF SOME ANTI-INFLAMMATORY DRUGS ON CAPILLARY PERMEABILITY OF THE GASTRIC MUCOSA IN THE RATThe Japanese Journal of Pharmacology, 1969